BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29587824)

  • 1. Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.
    Zhou D; Alver BM; Li S; Hlady RA; Thompson JJ; Schroeder MA; Lee JH; Qiu J; Schwartz PH; Sarkaria JN; Robertson KD
    Genome Biol; 2018 Mar; 19(1):43. PubMed ID: 29587824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity.
    Palanichamy K; Jacob JR; Litzenberg KT; Ray-Chaudhury A; Chakravarti A
    EBioMedicine; 2018 Oct; 36():281-292. PubMed ID: 30269995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
    Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
    Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.
    Herrmann A; Lahtz C; Song J; Aftabizadeh M; Cherryholmes GA; Xin H; Adamus T; Lee H; Grunert D; Armstrong B; Chu P; Brown C; Lim M; Forman S; Yu H
    Oncogene; 2020 Mar; 39(10):2156-2169. PubMed ID: 31819166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
    Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
    Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of DNA methylation alterations in paediatric glioma stem cells following fractionated dose irradiation.
    Danielsson A; Barreau K; Kling T; Tisell M; Carén H
    Clin Epigenetics; 2020 Feb; 12(1):26. PubMed ID: 32046773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Tet proteins in enhancer activity and telomere elongation.
    Lu F; Liu Y; Jiang L; Yamaguchi S; Zhang Y
    Genes Dev; 2014 Oct; 28(19):2103-19. PubMed ID: 25223896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
    Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
    Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable 5-Hydroxymethylcytosine (5hmC) Acquisition Marks Gene Activation During Chondrogenic Differentiation.
    Taylor SE; Li YH; Smeriglio P; Rath M; Wong WH; Bhutani N
    J Bone Miner Res; 2016 Mar; 31(3):524-34. PubMed ID: 26363184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts.
    Okada M; Suzuki S; Togashi K; Sugai A; Yamamoto M; Kitanaka C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.
    Yang W; Liu Y; Gao R; Yu H; Sun T
    Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling.
    Gimple RC; Kidwell RL; Kim LJY; Sun T; Gromovsky AD; Wu Q; Wolf M; Lv D; Bhargava S; Jiang L; Prager BC; Wang X; Ye Q; Zhu Z; Zhang G; Dong Z; Zhao L; Lee D; Bi J; Sloan AE; Mischel PS; Brown JM; Cang H; Huan T; Mack SC; Xie Q; Rich JN
    Cancer Discov; 2019 Sep; 9(9):1248-1267. PubMed ID: 31201181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells.
    Kawamura Y; Takouda J; Yoshimoto K; Nakashima K
    Cell Biol Toxicol; 2018 Dec; 34(6):425-440. PubMed ID: 29383547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Sareddy GR; Viswanadhapalli S; Surapaneni P; Suzuki T; Brenner A; Vadlamudi RK
    Oncogene; 2017 Apr; 36(17):2423-2434. PubMed ID: 27893719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.